TG Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF89.12 | CHF105.00 | 20.68% | 9 | CHF181.47B |
| SAN | Sanofi | Outperform |
16
|
87.70€ | 102.80€ | 24.29% | 9 | 108.49€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.86 | $58.15 | 12.57% | 10 | $99.17B |
| MRK | Merck KGaA | Outperform |
18
|
152.35€ | 190.06€ | 20.12% | 4 | 63.48€B |
| BIIB | Biogen | Outperform |
10
|
$201.99 | $299.62 | 41.10% | 13 | $29.36B |
| BAYN | Bayer | Hold |
5
|
26.97€ | 45.15€ | 18.65% | 4 | 25.86€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.97k | kr2.71k | 30.07% | 14 | kr130.39B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.01 | $11.59 | 22.98% | 9 | $14.57B |
| ALKS | Alkermes | Outperform |
10
|
$24.65 | $33.27 | 37.93% | 3 | $4.04B |